Identification | More | [Name]
5-Nitrouracil | [CAS]
611-08-5 | [Synonyms]
2,4(1H,3H)-PYRIMIDINEDIONE-5-NITRO 2,4-DIHYDROXY-5-NITROPYRIMIDINE 5-NITRO-2,4-DIHYDROXYPYRIMIDINE 5-NITRO-2,4-PYRIMIDINEDIOL 5-NITROPYRIMIDINE-2,4(1H,3H)-DIONE 5-NITROPYRIMIDINE-2,4-DIOL 5-NITROURACIL NITROURACIL 2,4-Dihydroxy-5-nitropyrimidin 3h)-pyrimidinedione,5-nitro-4(1h 5-Nitro-1H-pyrimidine-2,4-dione 5-Nitro-2,4(1H,3H)-pyrimidindion 5-nitrouracil(2,4-dihydroxy-5-nitropyrimidine) 5-Nitrouracil,99% 5-NITROURACIL/PRAZOSIN DOXAZOSIN 5-nitro-4(1h,3h)-pyrimidinedione 5-NITRO-PYRIMIDIN-2,4-DIOL 5-NITROURACIL, 98+% 5-NITROURACIL extrapure Uracil, 5-nitro- | [EINECS(EC#)]
210-250-4 | [Molecular Formula]
C4H3N3O4 | [MDL Number]
MFCD00006021 | [Molecular Weight]
157.08 | [MOL File]
611-08-5.mol |
Chemical Properties | Back Directory | [Appearance]
Off-White Solid | [Melting point ]
>300 °C(lit.)
| [Boiling point ]
281.7°C (rough estimate) | [density ]
1.8278 (rough estimate) | [refractive index ]
1.5000 (estimate) | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
DMSO, Water | [form ]
Crystalline Powder or Needles | [pka]
5.19±0.10(Predicted) | [color ]
Off-white to pale yellow | [Water Solubility ]
3.61g/L(25 ºC) | [BRN ]
10410 | [InChI]
InChI=1S/C4H3N3O4/c8-3-2(7(10)11)1-5-4(9)6-3/h1H,(H2,5,6,8,9) | [InChIKey]
TUARVSWVPPVUGS-UHFFFAOYSA-N | [SMILES]
C1(=O)NC=C([N+]([O-])=O)C(=O)N1 | [CAS DataBase Reference]
611-08-5(CAS DataBase Reference) | [EPA Substance Registry System]
611-08-5(EPA Substance) |
Safety Data | Back Directory | [Hazard Codes ]
F,C | [Risk Statements ]
R11:Highly Flammable. R34:Causes burns. | [Safety Statements ]
S22:Do not breathe dust . S24/25:Avoid contact with skin and eyes . S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S16:Keep away from sources of ignition-No smoking . | [WGK Germany ]
2
| [RTECS ]
UV9104545
| [TSCA ]
Yes | [HS Code ]
29335900 |
Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Definition]
ChEBI: 5-nitrouracil is a C-nitro compound consisting of uracil having a nitro group at the 5-position. It is functionally related to a uracil. | [Synthesis]
The general procedure for the synthesis of 5-nitropyrimidine-2,4(1H,3H)-dione from pyrimidine-2,4(1H,3H)-dione: Nitric acid solution (5.34 mL, 120 mmol, 70% solution) was added drop-wise to concentrated sulfuric acid (19.7 mL, 360 mmol, 98% solution) under the condition of the temperature not exceeding 50 ℃. Subsequently, pyrimidine-2,4(1H,3H)-dione (7.204 g, 60 mmol) was added to the stirred mixed acid solution in batches while controlling the reaction temperature not to exceed 50°C. The reaction mixture was heated to 55 °C and maintained for 3 h, after which it was cooled below room temperature and the reaction was quenched with ice water (38 mL). The resulting white precipitate was collected by filtration, washed with a small amount of ice water and dried under reduced pressure at 55 °C to afford 5-nitropyrimidine-2,4(1H,3H)-dione (8.658 g, 55.11 mmol, 92% yield) as a white solid. Product properties: decomposition temperature >288°C; thin layer chromatography Rf value 0.00 (unfolding agent ratio 1:10 ethyl acetate/hexane); IR spectrum (ZnSe pool, solid) vmax: 3142-2811 cm^-1 (medium, broad, OH/NH/CH), 1732 cm^-1 (strong, C=O), 1677 and 1624 cm^-1 (strong. NO2), 1417 cm^-1 (medium, CH), 1356 cm^-1 (medium, NO2), 1318 cm^-1 (strong, aromatic R2NH/R3N), 1234 cm^-1 (strong, -OH), 975 and 832 cm^-1 (weak, aromatic ring bending); 1H NMR (500 MHz, d6-DMSO): δ 8.84 ( 1H, single peak, 6-CH) ppm; 13C NMR (125 MHz, d6-DMSO): δ 155.5 (4-C=O), 149.8 (6-CH), 147.9 (2-C=O), 125.1 (5-CNO2) ppm. | [Purification Methods]
The uracil recrystallises in prisms from boiling H2O as the monohydrate and loses H2O on drying in vacuo. [UV: Brown J Chem Soc 3647 1959, Brown J Appl Chem 2 239 1952, Johnson J Am Chem Soc 63 263 1941, Beilstein 24 I 313, 24 II 171, 24 III/IV 1236.] | [References]
[1] European Journal of Medicinal Chemistry, 2015, vol. 95, p. 29 - 34 [2] American Chemical Journal, 1905, vol. 33, p. 443 [3] American Chemical Journal, 1908, vol. 40, p. 31 [4] Journal of Biological Chemistry, 1908, vol. 4, p. 410 [5] Journal of the American Chemical Society, 1919, vol. 41, p. 786 |
|
|